Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe record history now shows a new latest revision, v3.5.3, replacing the previous v3.5.2. This marks a minor platform update to the page's revision metadata.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded an entry for Revision: v3.5.2 and removed Revision: v3.5.0 in the page's revision history. This reflects an incremental update to the historical record, without altering the main content presented to users.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedTerminated status was added to the study record history, and new sections Oversight, Study Status, and Study Identification were introduced. The previous Active, not recruiting status and related status details were removed.SummaryDifference1%

- Check44 days agoChange DetectedA new revision v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.4.2) was added, and outdated notices about funding and operating status (including v3.4.1) were removed. These updates concern the site’s version history and notices rather than the study details.SummaryDifference0.7%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.